What are the signs and symptoms of Nipah virus infection in adults, particularly older adults with underlying medical conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Signs and Symptoms of Nipah Virus Infection in Adults

Nipah virus infection presents most commonly with fever, followed by neurological manifestations including altered mental status and respiratory distress, with a mortality rate exceeding 70% in documented cases. 1

Initial Presenting Symptoms

The early clinical presentation is typically nonspecific and includes:

  • Fever occurs in approximately 80% of cases and is the most common initial symptom 1
  • Myalgia (muscle pain) affects 47% of patients 1
  • Headache is present in 47% of cases 1
  • Vomiting occurs in 42.6% of patients 1

These initial symptoms typically develop 5-14 days after exposure, though the incubation period can range from 4 days to 2 weeks. 2, 3

Neurological Manifestations

Nipah virus characteristically causes severe encephalitis with distinctive neurological features:

  • Altered sensorium (depressed consciousness) develops in 44.1% of cases and represents a critical warning sign 1
  • Seizures are a common complication, occurring in 39.2% of patients 1
  • Myoclonic jerks may occur, though less commonly than in other viral encephalitides 4
  • Focal neurological deficits including weakness, cranial nerve palsies, and movement disorders can develop 5
  • Progressive encephalitis with deteriorating mental status is characteristic of severe disease 3, 5

The neurological deterioration can be rapid, with patients progressing from mild confusion to coma within days. 4

Respiratory Manifestations

Respiratory involvement is a prominent feature, particularly in older adults with underlying conditions:

  • Shortness of breath and acute respiratory distress syndrome (ARDS) occur in 44.1% of cases 1
  • Severe respiratory distress requiring mechanical ventilation develops in a substantial proportion of patients 4
  • Respiratory failure is a major cause of mortality and can develop rapidly 3

The respiratory syndrome may occur concurrently with or independently of neurological symptoms. 5

Clinical Course and Complications

The disease progression follows a characteristic pattern:

  • Rapid deterioration is common, with patients requiring ICU-level care within days of symptom onset 4
  • Altered consciousness persisting or worsening despite supportive care indicates severe disease 1
  • Seizures and status epilepticus require aggressive anticonvulsant therapy 4
  • Vasculitis and thrombotic complications can occur, manifesting as stroke-like episodes or multifocal brain lesions 6

Neuroimaging Findings

Brain MRI abnormalities are present in the majority of symptomatic cases:

  • Small infarcts and areas of cytotoxic edema are common findings 6
  • Vasogenic edema may develop in more severe cases 6
  • Multifocal lesions can appear throughout the brain, including white matter involvement 6
  • Inflammatory changes with perivascular infiltrates may be visible 6

These imaging findings help distinguish Nipah virus encephalitis from other causes of acute encephalitis. 6

High-Risk Features in Older Adults

Older adults with underlying medical conditions face particularly high risk:

  • Pre-existing cardiovascular disease may worsen outcomes due to the vasculitic component of Nipah infection 6
  • Diabetes and hypertension are common comorbidities that complicate management 1
  • Immunocompromised states may lead to more severe or atypical presentations 3
  • Rapid progression to respiratory failure is more common in older patients with underlying lung disease 4

Critical Warning Signs Requiring Immediate Escalation

The following features indicate imminent treatment failure and require immediate consideration of intubation rather than prolonged trials of non-invasive support: 4

  • Persistent or worsening altered consciousness despite initial resuscitation
  • Respiratory rate persistently >25 breaths per minute
  • Rapid desaturation when disconnected from oxygen support
  • New onset confusion or severe agitation
  • Signs of impending respiratory arrest

Do not delay intubation by attempting prolonged trials of non-invasive ventilation or high-flow nasal oxygen, as this increases mortality and puts healthcare workers at risk during emergency intubation. 4

Mortality and Prognosis

The overall mortality rate for Nipah virus infection is 73.9% in documented case series, making it one of the most lethal emerging viral infections. 1 Death typically results from progressive encephalitis, respiratory failure, or cardiovascular collapse. 3, 5

Human-to-human transmission occurs in approximately 50% of cases, primarily through contact with infected patients' respiratory secretions or saliva, necessitating strict airborne precautions with N-95 respirators for all healthcare workers. 4, 2

References

Research

Transmission of human infection with Nipah virus.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009

Research

Nipah Virus Infection.

Journal of clinical microbiology, 2018

Guideline

Nipah Virus Infection Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the management and treatment approach for a patient suspected of Nipah virus infection, particularly one with symptoms such as fever, headache, and respiratory distress, and recent travel history to endemic areas or exposure to animals?
What is the prognosis and treatment for a patient suspected of having Nipah virus infection?
How did the patient get infected with Nipah virus?
What is the management and treatment approach for a child suspected of having Nipah virus infection?
What are the symptoms and treatment options for a patient suspected of having Nipah virus infection?
What are the newer treatment options for a patient with localized pustular psoriasis (LPP) and a history of gastrointestinal symptoms, considering their potential history of psoriasis or psoriatic arthritis?
What are the management options for a patient with hypotension, on telmisartan (angiotensin II receptor antagonist) 20mg, with a blood pressure of 96/60?
What are the characteristics, typical presentation, and diagnostic approaches for dermatofibroma in adults?
What are the recommended doses of antibiotics, such as gentamicin, vancomycin, ciprofloxacin, and levofloxacin, for patients with impaired renal function?
What is the recommended dose of anidulafungin (echinocandin antifungal) for an elderly female patient with impaired renal function and a fungal infection?
What are the considerations for using mirtazapine and duloxetine (antidepressants) together in adult patients with major depressive disorder?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.